NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/09/2026
Back to search
Official data from USPTO
ONKORD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
07/09/2026
Trademark type
Word
Nice classes
5
Filing date
03/30/2017
Registration date
11/14/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/03/2023
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Oss, NL
Examiner
CORWIN, CHARLOTTE K
Law office
N10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Glycostem Therapeutics B.V.
IPD Therapeutics B.V.
Representatives
Michael M. Morris Woodard Emhardt Moriarty McNett & Henry LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cell products for treating cancercells for medical use in the field of immuno-oncology
Publications
History of USPTO decisions and trademark events.
31 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/08/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/03/2023
71AG
REGISTERED-SEC.71 ACCEPTED
07/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/03/2023
ES71
TEAS SECTION 71 RECEIVED
12/13/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/14/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/24/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/13/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/20/2018
FIMP
FINAL DISPOSITION PROCESSED
02/20/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/14/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2017
PUBO
PUBLISHED FOR OPPOSITION
08/29/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2017
RFNT
REFUSAL PROCESSED BY IB
07/21/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/17/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/17/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/14/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/14/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/01/2017
RFRR
REFUSAL PROCESSED BY MPU
07/01/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/24/2017
CNRT
NON-FINAL ACTION WRITTEN
06/23/2017
DOCK
ASSIGNED TO EXAMINER
06/21/2017
MAFR
APPLICATION FILING RECEIPT MAILED
06/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/01/2017
Continuous trademark protection
Get notified about every new filing that threatens ONKORD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.